Place conditioning with the dopamine D1-like receptor agonist SKF 82958 but not SKF 81297 or SKF 77434

European Journal of Pharmacology

Volumn 343, Issue 2-3, 1998, Pages 111-118

  Abrahams, Brett S ^a   Rutherford, Jeff D ^a   Mallet, Paul E ^a   Beninger, Richard J ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

Dopamine; Dopamine D1 like like receptor; Learning, reward related; Place conditioning; SKF 77434; SKF 81297; SKF 82958

Indexed keywords

3 ALLYL 2,3,4,5 TETRAHYDRO 1 PHENYL 1H 3 BENZAZEPINE 7,8 DIOL; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; AMPHETAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONDITIONING; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LEARNING; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; SUBCUTANEOUS DRUG ADMINISTRATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BENZAZEPINES; CONDITIONING, OPERANT; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MOTOR ACTIVITY; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1;

EID: 0032545994     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01531-8     Document Type: Article

References (48)

1. 1 receptor efficacy. Eur. J. Pharmacol. 188:1990;335-347.
2. Anderson P.H., Grønvald F.C., Jansen J.A. A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum. Life Sci. 37:1985;1971-1983.
3. Arnt J., Hyttel J., Sanchez C. Partial and full dopamine D1-receptor agonists in mice and rats-relation between behavioural effects and stimulation of adenylate cyclase activity in vitro. Eur. J. Pharmacol. 213:1992;259-267.
4. Beninger, R.J., 1993. Role of D1 and D2 receptors in learning. In: Waddington. J. (Ed.), D1:D2 Dopamine Receptor Interactions: Neuroscience and Pharmacology. Academic Press, Amsterdam, pp. 115-157.
5. Beninger, R.J., Miller, R., 1997. Dopamine D1-like receptors and reward-related incentive learning. Neurosci. Biobehav. Rev., in press.
6. Beninger, R.J., Nakonechny, P.L., 1996. Dopamine D1-like receptors and molecular mechanisms of incentive learning. In: Beninger, R.J., Palomo, T., Archer, T. (Eds.), Dopamine Disease States. CYM Press, Madrid, pp. 407-431.
7. Beninger R.J., Rolfe N.G. Dopamine D1-like receptor agonists impair responding for conditioned reward in rats. Behav. Pharmacol. 6:1995;785-793.
8. 2 antagonists. Behav. Pharmacol. 1:1990;355-364.
9. Brockwell N.T., Beninger R.J. The differential role of A1 and A2 adenosine receptor subtypes in locomotor activity and place conditioning in rats. Behav. Pharmacol. 7:1996;373-383.
10. Brockwell N.T., Ferguson D.S., Beninger R.J. A computerized system for the simultaneous monitoring of place conditioning and locomotor activity in rats. J. Neurosci. Methods. 64:1996;227-232.
11. Caine S.B., Koob G.F. Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J. Pharmacol. Exp. Ther. 270:1994;209-218.
12. Carr, G.D., Fibiger, H.S., Phillips A.G., 1989. Conditioned place preference as a measure of drug reward. In: Liebman, J.M., Cooper, S.J. (Eds.), The Neuropharmacological Basis of Reward. Clarendon Press, Oxford, pp. 264-319.
13. Corrigall W.A., Coen S.J. Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol. Biochem. Behav. 39:1991;799-802.
14. De Wit H., Wise R.A. Blockade of cocaine reinforcement in rats with the DA receptor blocker pimozide, but not the NA blockers phentolamine or phenoxybenyamine. Can. J. Psychol. 31:1977;195-203.
15. Grech D.M., Spealman R.D., Bergman J. Self-administration of D1 receptor agonists by squirrel monkeys. Psychopharmacology. 125:1996;97-104.
16. Hahn Jr., R.A., Wardell, J.R., Sarau, H.M., Ridley, P.T., 1982. Characterization of the peripheral and central effects of SK and F 82526, a novel dopamine receptor agonist. J. Pharmacol. Exp. Ther. 223, 305-313.
17. Hiroi N., White N.M. The amphetamine conditioned place preference - Differential involvement of dopamine receptor subtypes and two dopaminergic terminal areas. Brain Res. 552:1991;141-152.
18. Hoffman D.C. The use of place conditioning in studying the neuropharmacology of drug reinforcement. Brain Res. Bull. 24:1989;373-387.
19. Hoffman D.C., Beninger R.J. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning. Pharmacol. Biochem. Behav. 31:1988;1-8.
20. Hoffman D.C., Beninger R.J. The effects of selective dopamine D1 and D2 receptor antagonists on the establishment of agonist-induced place conditioning in rats. Pharmacol. Biochem. Behav. 33:1989;273-279.
21. Hoffman D.C., Dickson P.R., Beninger R.J. The dopamine D2 receptor agonists, quinpirole and bromocriptine produce conditioned place preferences. Prog. Neuro-Psychopharmacol. Biol. Psychiatr. 12:1988;315-322.
22. Izenwasser S., Katz J.L. Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur. J. Pharmacol. 246:1993;39-44.
23. Kebabian J.W., Calne D.B. Multiple receptors for dopamine. Nature. 277:1979;93-96.
24. Koob G.F., Le H.T., Creese I. The D1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci. Lett. 79:1987;315-320.
25. Mackey W.B., van der Kooy D. Neuroleptics block the positive reinforcing effects of amphetamine but not of morphine as measured by place conditioning. Pharmacol. Biochem. Behav. 22:1985;101-106.
26. Meyer M.E., Shults J.M. Dopamine D1 receptor family agonists, SK and F77434, and SK and F82958, differentially affect locomotor activities in rats. Pharmacol. Biochem. Behav. 46:1993;269-274.
27. Miller R., Wickens J.R., Beninger R.J. Dopamine D-1 and D-2 receptors in relation to reward and performance: A case for the D-1 receptor as a primary site of therapeutic action of neuroleptic drugs. Prog. Neurobiol. 34:1990;143-183.
28. Mithani S., Martin-Iverson M.T., Phillips A.G., Fibiger H.C. The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity. Psychopharmacology. 90:1986;247-252.
29. Morency M.A., Beninger R.J. Dopaminergic substrates of cocaine-induced place conditioning. Brain Res. 399:1986;33-41.
30. Murray A.M., Waddington J.L. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: Two directions of D-1:D-2 interaction. Eur. J. Pharmacol. 160:1989;377-384.
31. O'Boyle K.M., Gaitanopoulos D.E., Brenner M., Waddington J.L. Agonist and antagonist properties of benzazepines and thienopyridine derivatives at the D1 dopamine receptor. Neuropharmacology. 28:1989;401-404.
32. Risner J.E., Jones B.E. Role of noradrenergic and dopaminergic processes in amphetamine self-administration. Pharmacol. Biochem. Behav. 5:1976;477-482.
33. Roberts D.C.S., Vickers G. Atypical neuroleptics increase self-administration of cocaine: An evaluation of a behavioural screen for antipsychotic activity. Psychopharmacology. 82:1984;135-137.
34. Roberts D.C.S., Vickers G. The effect of haloperidol on cocaine self-administration is augmented with repeated administrations. Psychopharmacology. 93:1987;526-528.
35. Seeman P., Van Tol H.H.M. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 15:1994;264-270.
36. Self D.W., Stein L. The D1 agonists SKF. 82958 and SKF 77434 are self administered by rats Brain Res. 582:1992;349-352.
37. Self, D.W., Lam, D.M., Kossuth, S.R., Stein, L., 1993. Effects of D1 and D2-selective antagonists on self-administration of the D1 agonist SKF 82958. In: Harris, L. (Eds.), NIDA Research Monograph 132, College on the Problems of Drug Dependence. NIDA, Washington, DC, p. 230.
38. Self D.W., Belluzzi J.D., Kossuth S., Stein L. Self-administration of the D1 agonist SKF. 82958 is mediated by D1, not D2, receptors Psychopharmacology. 123:1996;303-306.
39. Spyraki C., Fibiger H.C., Phillips A.G. Attenuation by haloperidol of place preference conditioning using food reinforcement. Psychopharmacology. 77:1982;379-382.
40. Ungerstedt, U., 1979. Central dopamine mechanisms of unconditioned behaviour. In: Horn, A.S., Korf, J., Westerink, B.H.C. (Eds.), The Neurobiology of Dopamine. Academic Press, London, pp. 577-596.
41. Weed M.R., Vanover K.E., Woolverton W.L. Reinforcing effects of the D1 dopamine agonist SKF. 81297 in rhesus monkeys Psychopharmacology. 113:1993;51-52.
42. Weed M.R., Woolverton W.L. The reinforcing effects of dopamine D1 receptor agonists in rhesus monkeys. J. Pharmacol. Exp. Ther. 275:1995;1367-1374.
43. White N.M., Packard M.G., Hiroi N. Place conditioning with D1 and D2 agonists injected peripherally or into the nucleus accumbens. Psychopharmacology. 103:1991;271-276.
44. Wise R.A., Murray A., Bozarth M.A. Bromocriptine self-administration and bromocriptine-reinstatement of cocaine-trained and heroin-trained lever pressing in rats. Psychopharmacology. 100:1990;355-361.
45. Willner, P., Scheel-Krüger, J. (Eds.), 1991. The Mesolimbic Dopamine System: From Motivation to Action. John Wiley and Sons, Chichester.
46. Woolverton W.L., Goldberg L.I., Ginos J.Z. Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J. Pharmacol. Exp. Ther. 230:1984;678-683.
47. Yokel R.A., Wise R.A. Increased lever pressing for amphetamine after pimozide in rats: Implications for a dopamine theory of reward. Science. 187:1975;547-549.
48. Yokel R.A., Wise R.A. Attenuation of intravenous amphetamine reinforcement by central DA blockade in rats. Psychopharmacology. 48:1976;311-318.